368 filings
Page 5 of 19
424B5
fzvv2iuv67 ciy
20 Sep 21
Prospectus supplement for primary offering
4:12pm
8-K
xt9k76oi4xtw6eww
11 Aug 21
Viridian Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
7:17am
8-K
tngso3h c97dmpvr93
26 Jul 21
Viridian Therapeutics Appoints Kristian Humer As Chief
7:35am
8-K
b38ne 95ba3o
15 Jul 21
Viridian Therapeutics Appoints Jennifer Moses, Cpa to the Board of Directors and As Chair of the Audit Committee
4:13pm
8-K/A
d5ht3ekv7f5m
15 Jun 21
Amendments to Articles of Incorporation or Bylaws
5:30pm
DEFA14A
hskju
4 Jun 21
Additional proxy soliciting materials
6:13am
8-K
v23749l
4 Jun 21
Departure of Directors or Certain Officers
6:08am
8-K
bhymc3myb
17 May 21
Departure of Directors or Certain Officers
4:04pm
8-K
vjj5dwio
6 May 21
Viridian Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates
4:09pm
8-K
c6xvbnt
26 Apr 21
Entry into a Material Definitive Agreement
12:00am
424B3
5hx1qtz7
23 Apr 21
Prospectus supplement
5:30pm
424B5
ffyy4yc 2f
23 Apr 21
Prospectus supplement for primary offering
5:28pm
S-8
khq01ryett6sfvhmvgj
26 Mar 21
Registration of securities for employees
4:22pm
8-K
jokn7dkeg5dxa3
25 Mar 21
Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate Updates
4:06pm
8-K
aym4yhdjalff
20 Jan 21
Departure of Directors or Certain Officers
8:01am